Lannett Enters Supply And Distribution Agreement For Levothyroxine

Lannett enters into an agreement with Cediprof for an exclusive 10-year future supply and distribution agreement of levothyroxine starting 1 August 2022.

Molecule
Lannett re-enters the Levothyroxine Space with Cediprof • Source: Shutterstock

More from Deals

More from Business